sottoscrivi

Accedi

Osborne Clarke advises Sylphar NV and Karo Pharma AB on purchase

Osborne Clarke advises Sylphar NV and Karo Pharma AB on purchase

Dr Tim Reinhard - Osborne Clarke

Osborne Clarke Osborne Clarke Marketing Law

Alexandra Nautsch – Global Legal Chronicle

White & Case Advises Karo Pharma on Acquisition of Sylphar International

Osborne Clarke – Page 26 – Global Legal Chronicle

Commercial, corporate and M&A in Belgium Law firm and lawyer rankings from The Legal 500 Europe, Middle East & Africa guide

Dr Hendrik Schöttle - Osborne Clarke

Karo Intressenter AB completed the acquisition of remaining 13.6% stake in Karo Pharma AB (OM : KARO). -November 23, 2022

Nora Hendricks-Wirtz - Osborne Clarke

Sweden's Karo Pharma to buy Sylphar in $326 million deal